2,865 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 213 funds opening new positions, 1,177 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,177 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.1%65.94% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,865
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
2526
$222K
2527
$222K
2528
$221K
2529
$221K
2530
$220K
2531
$220K
2532
$220K
2533
$220K
2534
$220K
2535
$219K
2536
$218K
2537
$218K
2538
$218K
2539
$218K
2540
$218K
2541
$218K
2542
$218K
2543
$217K
2544
$217K
2545
$216K
2546
$216K
2547
$216K
2548
$216K
2549
$216K
2550
$215K